Cite
An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.
MLA
Clarke, Loren E., et al. “An Independent Validation of a Gene Expression Signature to Differentiate Malignant Melanoma from Benign Melanocytic Nevi.” Cancer (0008543X), vol. 123, no. 4, Feb. 2017, pp. 617–28. EBSCOhost, https://doi.org/10.1002/cncr.30385.
APA
Clarke, L. E., Flake, D. D., Busam, K., Cockerell, C., Helm, K., McNiff, J., Reed, J., Tschen, J., Kim, J., Barnhill, R., Elenitsas, R., Prieto, V. G., Nelson, J., Kimbrell, H., Kolquist, K. A., Brown, K. L., Warf, M. B., Roa, B. B., Wenstrup, R. J., & Flake, D. D., 2nd. (2017). An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer (0008543X), 123(4), 617–628. https://doi.org/10.1002/cncr.30385
Chicago
Clarke, Loren E., Darl D. Flake, Klaus Busam, Clay Cockerell, Klaus Helm, Jennifer McNiff, Jon Reed, et al. 2017. “An Independent Validation of a Gene Expression Signature to Differentiate Malignant Melanoma from Benign Melanocytic Nevi.” Cancer (0008543X) 123 (4): 617–28. doi:10.1002/cncr.30385.